Literature DB >> 30280206

[Update on endocrine hypertension].

B Lechner1, D Heinrich2, S Nölting2, A Osswald-Kopp2, G Rubinstein2, J Sauerbeck3, F Beuschlein2, M Reincke2.   

Abstract

Endocrine disorders are the most common causes of secondary hypertension. Early diagnosis and specific treatment are crucial for improvement of the prognosis. This article provides an overview on which clinical constellations point to an increased risk of secondary causes of hypertension. These include spontaneous hypokalemia, young age at onset of hypertension, adrenal incidentaloma and therapy refractive arterial hypertension. The basic diagnostics include determination of the aldosterone to renin ratio, measurement of free plasma metanephrines and a 1 mg dexamethasone suppression test. Borderline results require repeated control testing and/or confirmatory testing under standardized test conditions. In cases of repeatedly conspicuous results referral to a specialized clinic should be considered for further clarification and confirmation of the diagnosis. Imaging diagnostics may constitute an adjunct to laboratory testing after the diagnosis has been confirmed. Therapeutic algorithms vary depending on the underlying endocrine disease.

Entities:  

Keywords:  Cushing syndrome; Hypertension, secondary; Paraganglioma; Pheochromocytoma; Primary aldosteronism

Mesh:

Year:  2018        PMID: 30280206     DOI: 10.1007/s00108-018-0505-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

Review 1.  Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.

Authors:  Gian Paolo Rossi; Teresa M Seccia; Achille C Pessina
Journal:  Crit Rev Clin Lab Sci       Date:  2007       Impact factor: 6.250

Review 2.  Diagnosis and Differential Diagnosis of Cushing's Syndrome.

Authors:  D Lynn Loriaux
Journal:  N Engl J Med       Date:  2017-04-13       Impact factor: 91.245

3.  Guidelines for primary aldosteronism: uptake by primary care physicians in Europe.

Authors:  Paolo Mulatero; Silvia Monticone; Jacopo Burrello; Franco Veglio; Tracy A Williams; John Funder
Journal:  J Hypertens       Date:  2016-11       Impact factor: 4.844

4.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

5.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

6.  Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.

Authors:  Elena Valassi; Holger Franz; Thierry Brue; Richard A Feelders; Romana Netea-Maier; Stylianos Tsagarakis; Susan M Webb; Maria Yaneva; Martin Reincke; Michael Droste; Irina Komerdus; Dominique Maiter; Darko Kastelan; Philippe Chanson; Marija Pfeifer; Christian J Strasburger; Miklós Tóth; Olivier Chabre; Antoine Tabarin; Michal Krsek; Carmen Fajardo; Marek Bolanowski; Alicia Santos; John A H Wass; Peter J Trainer
Journal:  Eur J Endocrinol       Date:  2017-05       Impact factor: 6.664

7.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

9.  Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.

Authors:  Gregory L Hundemer; Gary C Curhan; Nicholas Yozamp; Molin Wang; Anand Vaidya
Journal:  Lancet Diabetes Endocrinol       Date:  2017-11-09       Impact factor: 32.069

10.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Authors:  Martin Fassnacht; Wiebke Arlt; Irina Bancos; Henning Dralle; John Newell-Price; Anju Sahdev; Antoine Tabarin; Massimo Terzolo; Stylianos Tsagarakis; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2016-08       Impact factor: 6.664

View more
  1 in total

Review 1.  [Pheochromocytoma and paraganglioma : Importance of diagnostic imaging].

Authors:  W G Kunz; C J Auernhammer; S Nölting; T Pfluger; J Ricke; C C Cyran
Journal:  Radiologe       Date:  2019-11       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.